HBA1C III TINA-QUANT HEMOGLOBIN A1C III HBA1C TQ G3 05336163190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2020-02-13 for HBA1C III TINA-QUANT HEMOGLOBIN A1C III HBA1C TQ G3 05336163190 manufactured by Roche Diagnostics.

MAUDE Entry Details

Report Number1823260-2020-00424
MDR Report Key9705661
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2020-02-13
Date of Report2020-03-26
Date of Event2020-01-14
Date Mfgr Received2020-01-24
Date Added to Maude2020-02-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameHBA1C III TINA-QUANT HEMOGLOBIN A1C III
Generic NameASSAY, GLYCOSYLATED HEMOGLOBIN
Product CodeLCP
Date Received2020-02-13
Model NumberHBA1C TQ G3
Catalog Number05336163190
Lot Number40125801
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2020-02-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.